Angelis Oncology
San Francisco, US · Founded 2026 · Delaware corporation
Find your way into Angelis Oncology
Sign up to see every warm intro you have to Angelis Oncology
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Angelis Oncology team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
DS
Daniel SantiPresident; Chief Executive Officer; Secretary; Treasurer
Reported raises · per SEC filings
Form D private placements$400K disclosed across 1 round · 2026
▶$400KraisedJul 2026 · 1 investors · BiotechnologyRule 506(b)
▶$400KraisedJul 2026 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Daniel SantiExecutive Officer, Director
- Amount sold
- $400K
- First sale
- Jul 2026
- Incorporated
- Corporation, Delaware, 2026
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Angelis Oncology raised?
- Angelis Oncology has disclosed $400K raised across 1 round.
- Where is Angelis Oncology headquartered?
- Angelis Oncology is headquartered in San Francisco, US.